• Return to Headlines

Iridex Shares Down 36.0% Since SmarTrend's Sell Call (IRIX)

By Shiri Gupta

SmarTrend identified a Downtrend for Iridex (NASDAQ:IRIX) on March 9th, 2017 at $14.09. In approximately 3 months, Iridex has returned 36.03% as of today's recent price of $9.01.

In the past 52 weeks, Iridex share prices have been bracketed by a low of $3.07 and a high of $16.64 and are now at $9.01, 193% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.9% while the 200-day MA has risen 1.1%.

IRIDEX Corporation provides semiconductor-based laser systems used to treat eye disease and skin lesions. The Company's products are sold around the world. IRIDEX markets its IRIS Medical products to the ophthalmic market, IRIDERM to the dermatological market, and Light Solutions to the research market.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Iridex.

Log in and add Iridex (IRIX) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights iridex

Ticker(s): IRIX